Biotech Values

[Rocky3]

the Lovenox patent case is considered urgent by nobody.

That was not the position stated by MNTA management at the annual meeting. Well, there didn't seem to be urguency, but surely was disappointment that the judge set the date when he did. It would extremely unusual for a plaintiff to want a long-date trial schedule. That is what management indicated - they wanted a much sooner date.

It would be very unusual for a judge to have any idea how fast a government agency might act, unless one of the parties makes a point to state the fact, and I find it very unlikely TEVA would state (voluntarily or non-voluntarily) that it did not expect to get approval anytime soon. So, I am with others on the intrepretation that the case gives very little indication as to the timing of TEVA approval.